相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lower cardiorenal risk withsodium-glucosecotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Kare I. Birkeland et al.
DIABETES OBESITY & METABOLISM (2021)
Socioeconomic inequalities and type 2 diabetes complications: A systematic review
S. Tatulashvili et al.
DIABETES & METABOLISM (2020)
Burden of Complications in US Adults With Young-Onset Type 2 or Type 1 Diabetes
Michael Fang et al.
DIABETES CARE (2020)
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Kare Birkeland et al.
DIABETES OBESITY & METABOLISM (2020)
Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus
Aidin Rawshani et al.
CIRCULATION (2019)
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction Subanalysis From the DECLARE-TIMI 58 Trial
Remo H. M. Furtado et al.
CIRCULATION (2019)
Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
You-Bin Lee et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)
Rachel G. Miller et al.
DIABETES (2019)
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Kare I. Birkeland et al.
DIABETES OBESITY & METABOLISM (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus
David A. McAllister et al.
CIRCULATION (2018)
Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011
Lili Huo et al.
DIABETOLOGIA (2018)
Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
Araz Rawshani et al.
LANCET (2018)
Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes
Jaakko Helve et al.
DIABETES CARE (2018)
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Kare I. Birkeland et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Type 1 diabetes mellitus
Anastasia Katsarou et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Clinical Update: Cardiovascular Disease in Diabetes Mellitus Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
Cecilia C. Low Wang et al.
CIRCULATION (2016)
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013
Anna Norhammar et al.
DIABETOLOGIA (2016)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Excess Mortality among Persons with Type 2 Diabetes
Mauro Tancredi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
NORDIC LONGITUDINAL DATA FROM ELECTRONIC MEDICAL RECORDS AND FULL POPULATION NATIONAL REGISTERS: UNIQUE OPPORTUNITIES FOR NEW INSIGHTS IN BENEFIT OF DIABETES PATIENTS
A. Lindh et al.
VALUE IN HEALTH (2015)
The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors
M. K. Svensson et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
David M. Nathan
DIABETES CARE (2014)
Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
Sarah D. de Ferranti et al.
DIABETES CARE (2014)
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
Sophia Zoungas et al.
DIABETOLOGIA (2014)
The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods
Araz Rawshani et al.
DIABETOLOGIA (2014)
Glycemic Control and Excess Mortality in Type 1 Diabetes
Marcus Lind et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Long-Term Complications and Mortality in Young-Onset Diabetes
Maria I. Constantino et al.
DIABETES CARE (2013)
Associations Between Socioeconomic Status and Major Complications in Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complication (EDC) Study
Aaron M. Secrest et al.
ANNALS OF EPIDEMIOLOGY (2011)
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study
T. J. Orchard et al.
DIABETOLOGIA (2010)
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
Per-Henrik Groop et al.
DIABETES (2009)
Follow-up of Intensive Glucose Control in Type 2 Diabetes
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Relationship between risk factors and mortality in type 1 diabetic patients in Europe - The EURODIAB Prospective Complications Study (PCS)
Sabita S. Soedamah-Muthu et al.
DIABETES CARE (2008)
Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects
Auni Juutilainen et al.
DIABETES CARE (2008)
The 30-year natural history of type 1 diabetes complications - The Pittsburgh epidemiology of diabetes complications study experience
G Pambianco et al.
DIABETES (2006)
Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management -: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
M Svensson et al.
DIABETES CARE (2003)
Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy
KN Drummond et al.
DIABETES (2003)